Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fIPV-dmLT vaccine for polio
NCT03922061Phase 1Completed
- Sponsor
- The University of Vermont
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes, Liposomes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dmLT in poliomyelitis, sponsored by The University of Vermont. Started Mar 2019; status: completed.
02
Drugs
dmLT
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03922061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03922061.